TigaTx is a new biopharmaceutical company engaged in research and development of innovative drugs for the treatment of cancer. We use so-called antibodies of the IgA type to target and activate certain immune cells of cancer pattens to fight the cancer. TigaTx stands for Targeted IgA Therapeutics. The cell type we target are called neutrophils.